Your browser doesn't support javascript.
loading
Variation in secondary prevention of coronary heart disease: the INTERASPIRE study.
McEvoy, John William; Jennings, Catriona; Kotseva, Kornelia; De Bacquer, Dirk; De Backer, Guy; Erlund, Iris; Vihervaara, Terhi; Lip, Gregory Y H; Ray, Kausik K; Rydén, Lars; Abreu, Ana; Almahmeed, Wael; Ambari, Ade Meidian; Ge, Junbo; Hasan-Ali, Hosam; Huo, Yong; Jankowski, Piotr; Jimenez, Rodney M; Li, Yong; Mahmood Zuhdi, Ahmad Syadi; Makubi, Abel; Mbakwem, Amam Chinyere; Mbau, Lilian; Navarro Estrada, Jose Luis; Ogah, Okechukwu Samuel; Ogola, Elijah Nyainda; Quintero-Baiz, Adalberto; Sani, Mahmoud Umar; Sosa Liprandi, Maria Ines; Tan, Jack Wei Chieh; Urina Triana, Miguel Alberto; Yeo, Tee Joo; Ganly, Sandra; Adamska, Agnieszka; Wood, David.
Afiliación
  • McEvoy JW; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland.
  • Jennings C; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland.
  • Kotseva K; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland.
  • De Bacquer D; Department of Cardiology, Imperial College London Healthcare NHS Trust, London, UK.
  • De Backer G; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Erlund I; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Vihervaara T; Biomarkers, Department of Government Services, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Lip GYH; Biomarkers, Department of Government Services, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Ray KK; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Rydén L; Department of Public Health and Primary Care, Imperial College London, London, UK.
  • Abreu A; Department of Medicine Solna, Karolinska Institutet, Stockholm 171 76, Sweden.
  • Almahmeed W; Faculty of Medicine, University of Lisbon (FMUL), University Hospital of Santa Maria, CHULN, Av. Egas Moniz, Lisbon 1649-082, Portugal.
  • Ambari AM; Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Al Mariah Island, Abu Dhabi, United Arab Emirates.
  • Ge J; National Cardiovascular Center Harapan Kita, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, West Jakarta, Jakarta, Indonesia.
  • Hasan-Ali H; Department of Cardiology, Institute of Cardiovascular Diseases, Fudan University Zhongshan Hospital, Floor 15, Building 16, No. 1609 Xietu Road, Xuhui District, Shanghai 200000, China.
  • Huo Y; Cardiovascular Medicine Department, Assiut University Heart Hospital, Assiut 71111, Egypt.
  • Jankowski P; Peking University First Hospital, Department of Cardiology, Institute of Cardiovascular Disease, No. 8 XiShiku Street, Xicheng District, Beijing 100034, China.
  • Jimenez RM; Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, 231 Czerniakowska St, Warsaw 00-416, Poland.
  • Li Y; Department of Adult Cardiology, University of the East Ramon Magsaysay Memorial Medical Center and St. Luke's Medical Center, Global City, Rizal Avenue Corner 32nd Street, Taguig City, Metro Manila, Philippines.
  • Mahmood Zuhdi AS; Department of Internal Medicine (Cardiology), Fudan University Huashan Hospital, 12 Wulumuqi Zhong Rd, Shanghai 200040, China.
  • Makubi A; Cardiology Unit, Department of Medicine, University Malaya Medical Centre, Kuala Lumpur 59100, Malaysia.
  • Mbakwem AC; Ministry of Health Community Development Gender Elderly and Children, Dar es salaam, Tanzania.
  • Mbau L; Department of Medicine, College of Medicine, University of Lagos, Idi Araba, Lagos, Nigeria.
  • Navarro Estrada JL; Kenya Cardiac Society, P.O. Box 8038-00100, Nairobi, Kenya.
  • Ogah OS; Department of Cardiology, Italian Hospital of Buenos Aires, Gascon, Buenos Aires 450 (1181), Argentina.
  • Ogola EN; Cardiology Unit, Department of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
  • Quintero-Baiz A; Department of Clinical Medicine and Therapeutics, University of Nairobi, P.O. Box 19676, Nairobi, Kenya.
  • Sani MU; Faculty of Health Sciences, University Simon Bolivar, Cra 50 # 80-216 Office 109 Barranquilla, Atlántico, Colombia.
  • Sosa Liprandi MI; Department of Medicine, Bayero University Kano and Aminu Kano Teaching Hospital, PMB 3452, Kano 700223, Kano State, Nigeria.
  • Tan JWC; Cardiology Service, University Hospital Sanatorio Güemes, Francisco Acuna de Figueroa 1240, Zip code 1180, Buenos Aires, Argentina.
  • Urina Triana MA; National Heart Centre Singapore, 5 Hospital Dr, Singapore 169609, Singapore.
  • Yeo TJ; Department of Cardiology, Duke-NUS Medical School, Singapore, Singapore.
  • Ganly S; Department of Cardiology, Sengkang General Hospital, Singapore, Singapore.
  • Adamska A; Faculty of Health Sciences, Universidad Simon Bolivar, Carrera 59 # 59-65, Barranquilla, Colombia.
  • Wood D; Cardiac Department, National University Heart Centre Singapore and National University Hospital, National University Health System (NUHS) Tower Block, 1E Lower Kent Ridge Road, Level 9, Singapore 119228, Singapore.
Eur Heart J ; 45(39): 4184-4196, 2024 Oct 14.
Article en En | MEDLINE | ID: mdl-39212219
ABSTRACT
BACKGROUND AND

AIMS:

INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in a timely manner.

METHODS:

Between 2020 and 2023, adults hospitalized in the preceding 6-24 months with incident or recurrent CHD were sampled in 14 countries from all 6 World Health Organization regions and invited for a standardized interview and examination. Direct age and sex standardization was used for country-level prevalence estimation.

RESULTS:

Overall, 4548 (21.1% female) CHD patients were interviewed a median of 1.05 (interquartile range .76-1.45) years after index hospitalization. Among all participants, 24.6% were obese (40.7% centrally). Only 38.6% achieved a blood pressure (BP) < 130/80 mmHg and 16.6% a LDL cholesterol (LDL-C) of <1.4 mmol/L. Of those smoking at hospitalization, 48% persisted at interview. Of those with known diabetes, 55.2% achieved glycated haemoglobin (HbA1c) of <7.0%. A further 9.8% had undetected diabetes and 26.9% impaired glucose tolerance. Females were less likely to achieve the targets BP (females 36.8%, males 38.9%), LDL-C (females 12.0%, males 17.9%), and HbA1c in diabetes (females 47.7%, males 57.5%). Overall, just 9.0% (inter-country range 3.8%-20.0%) reported attending cardiac rehabilitation and 1.0% (inter-country range .0%-2.4%) achieved the study definition of optimal guideline adherence.

CONCLUSIONS:

INTERASPIRE demonstrates inadequate and heterogeneous international implementation of guideline standards for secondary prevention in the first year after CHD hospitalization, with geographic and sex disparity. Investment aimed at reducing between-country and between-individual variability in secondary prevention will promote equity in global efforts to reduce the burden of CHD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Coronaria / Prevención Secundaria Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Coronaria / Prevención Secundaria Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Reino Unido